Top Stories
Research presented at ObesityWeek found that the company's AI-powered platform helped alleviate depression and anxiety, while reducing physical pain.
The agreement will see the companies combine their resources to hunt for small-molecule drug candidates targeting oncology.
The companies will combine clinical trial findings with real-world patient data to investigate treatment outcomes, including measures of health beyond weight loss.
The telehealth company plans to expand its diagnostic services and use its growing patient dataset to inform treatment decisions and clinical research.
The MIT spinout says six of the world's 20 largest drugmakers have partnered with it to access its biomolecular AI models.
Conference News
With the introduction of Imaging 360 AI assistant and embedded AI-assisted protocoling, Imaging 360 brings intelligence directly into the workflow, helping radiology teams access insights more effortl...
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a company building clinical AI tools to personalize cancer care, announced today that it will present nine studies at the 2026 San Antonio Breast Cancer Symposi...
Landmark NIH-funded study across nearly 2,400 participants validates circular RNA as a dynamic new molecular intelligence layer, capturing active changes across multiple neurodegenerative pathways yea...
The international academic study, led from Spain by Solti, in collaboration with Unicancer in France and WSG in Germany, has presented at ESMO AI & Digital Oncology 2026 a design that integrates digit...
As multimodal AI grows more sophisticated, FirstWord is asking oncologists whether it is making a difference in patient care -- or remains largely a promise.



